Financial Gravity Companies’s Impax Laboratories, Inc. IPXL Stock Holding History

Financial Gravity Companies’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$3K	Buy	+137	New	+$2.69K	﹤0.01%	909

Other funds holding IPXL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

TCW Group Los Angeles, California $14.9B AUM 46.29% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Financial Gravity Companies's IPXL Position: Q1 2018 in Review

Financial Gravity Companies opened a new position in Impax Laboratories, Inc. (IPXL) in Q1 2018: 137 shares worth $3K. The stake represents ﹤0.01% of the portfolio and ranks #909 among its holdings.

188 funds tracked by Wall St. Rank hold IPXL as of Q1 2018.

Financial Gravity Companies held 137 shares of Impax Laboratories, Inc. worth $3K as of Q1 2018.
Impax Laboratories, Inc. was a new Financial Gravity Companies position in Q1 2018.
Impax Laboratories, Inc. made up ﹤0.01% of Financial Gravity Companies's portfolio in Q1 2018, its #909 holding.
188 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q1 2018.

Based on Financial Gravity Companies's 13F filing for Q1 2018, filed 4 May 2018.